Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
株式のランク #94
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
株価
$44.42
時価総額
$197.32B
変化(1日)
-0.30%
変化(1年)
-20.41%
DK
取引 Novo Nordisk A/S (NOVO-B)

カテゴリー

Novo Nordisk A/S(NOVO-B)の株価履歴
終値の最高値: $46.13 (2026-09-01)

終値の最安値: $2.18 (2001-06-01)
Novo Nordisk A/S の株価履歴(2001 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -0.98%
2025 -52.90%
2024 4.17%
2023 52.14%
2022 18.40%
2021 58.24%
2020 22.06%
2019 25.41%
2018 -13.27%
2017 49.04%
2016 -38.00%
2015 26.90%
2014 26.23%
2013 10.09%
2012 43.00%
2011 5.11%
2010 62.81%
2009 25.51%
2008 -19.26%
2007 58.83%
2006 48.63%
2005 3.55%
2004 36.73%
2003 27.97%
2002 -21.13%
2001 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$1.14K 52.16%
US
$266.99 50.50%
US
$261.63 20.23%
US
$476.79 37.99%
CH
$144.70 78.60%
US